Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer
30 Mar, 2018 | 03:37h | UTCEffect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentaries: Higher-dose RT lowers risk of recurrence but does not improve survival for men with prostate cancer – eCancer News (free) AND Higher doses of radiation don’t improve overall survival for prostate cancer patients – OnMedica (free) AND Dose-Escalated RT Does Not Improve Survival in Intermediate-Risk PCa – Renal & Urology News (free) AND Higher Doses of Radiation Don’t Improve Survival in Prostate Cancer – Washington University in St. Louis, via NewsWise (free)